European Journal of Clinical Pharmacology

, Volume 49, Issue 6, pp 451–458

Haemodynamic interactions of a new calcium sensitizing drug levosimendan and captopril

  • S. Antila
  • L. Lehtonen
  • E.-P. Sandell
  • J. Eha
  • M. Heinpalu
  • I. Loogna
  • A. Mesikepp
  • U. Planken
Pharmacodynamics

DOI: 10.1007/BF00195930

Cite this article as:
Antila, S., Lehtonen, L., Sandell, EP. et al. Eur J Clin Pharmacol (1996) 49: 451. doi:10.1007/BF00195930

Abstract

Objective: Levosimendan in a new inodilator drug that sensitises troponin C in heart muscle cells to calcium, thus improving contractility. In previous studies, a single 2 mg intravenous dose of levosimendan increased cardiac output (CO) in healthy volunteers by about 40% and decreased pulmonary capillary wedge pressure in heart failure patients by 40–50%.

The aim of the present, double-blind study was to evaluate the safety of concomitant use of levosimendan and an ACE-inhibiting drug.

Methods: The haemodynamic effects of levosimendan, given with or without captopril, were evaluated by using 2-dimensional echocardiography, repeated blood pressure measurements and by ambulatory ECG recordings. Twenty-four male patients with stable NYHA II-III heart failure (EF<40%) after a previous myocardial infarct were given, in randomised order, a single IV infusion of levosimendan or placebo. The infusions were repeated after 2 weeks treatment with upto 50 mg b.i.d. of captopril. Twelve patients received levosimendan 1 mg and twelve received 2 mg.

Results: Mean CO was increased from 6.0 to 6.81·min−1 in patients receiving 1 mg levosimendan compared to placebo, but only from 6.3 to 6.51·min−1 in patients receiving 2 mg. The increase in CO was statistically significant when all levosimendan patients were compared to placebo. Heart rate did not change after either dose. Mean stroke volume increased significantly after 1 mg but not after 2 mg of levosimendan. The addition of captopril did not change the effects of levosimendan. No additional decrease in systolic or diastolic blood pressure was observed when levosimendan and captopril were given concomitantly.

Conclusion: It seems that concomitant treatment with captopril does not change the haemodynamic effects of levosimendan. No adverse haemodynamic interactions were seen.

Key words

Levosimendan Captopril calcium sensitizer inotropic drugs haemodynamics heart failure drug interaction 

Copyright information

© Springer-Verlag 1996

Authors and Affiliations

  • S. Antila
    • 1
  • L. Lehtonen
    • 1
  • E.-P. Sandell
    • 1
  • J. Eha
    • 2
  • M. Heinpalu
    • 2
  • I. Loogna
    • 2
  • A. Mesikepp
    • 2
  • U. Planken
    • 2
  1. 1.Orion-Farmos, Orion ResearchEspooFinland
  2. 2.Estonian Heart CenterTallinnEstonia

Personalised recommendations